Table1 Distribution of BSI pathogenic bacteria in CIN patients.

From: Inflammatory markers predict bloodstream infections risk in hematological malignancy patients with chemotherapy induced neutropenia

Pathogen name

Cases (n)

Proportion (%)

G −

 

Escherichia coli

28

25.00

Klebsiella pneumoniae subsp. pneumoniae

26

23.21

Pseudomonas aeruginosa

19

16.96

Klebsiella oxytoca

2

1.79

Enterobacter cloacae-complex

2

1.79

Klebsiella pneumoniae subsp. ozaenae

1

0.89

Aeromonas hydrophila

1

0.89

Stenotrophomonas maltophilia

1

0.89

Acinetobacter baumannii

1

0.89

Subtotal

 

81

72.32

G + 

 

Staphylococcus aureus

8

7.14

Bacillus cereus

3

2.68

Streptococcus mitis

2

1.79

Streptococcus pneumoniae

2

1.79

Enterococcus faecium

2

1.79

Streptococcus anginosus

1

0.89

Granulicatella adiacens

1

0.89

Staphylococcus hominis

1

0.89

Subtotal

 

20

17.86

Fungi

 

Candida tropicalis

3

2.68

Candida krusei

1

0.89

Subtotal

 

4

3.57

Mixed infections

 

K. pneumoniae subsp. pneumoniae/ A. hydrophila

2

1.79

E. coli / P. aeruginosa

1

0.89

P. aeruginosa / Staphylococcus cohnii

1

0.89

K. pneumoniae subsp. pneumoniae/ S. aureus

1

0.89

K. pneumoniae subsp. pneumoniae/ Streptococcus oralis

1

0.89

K. pneumoniae subsp. pneumoniae/ E. cloacae-complex

1

0.89

Subtotal

 

7

6.25

Total

112

100.00